MARSTACIMAB
UNII 0UB3OA67O7

Substance Identification & Data

This profile provides standardized clinical and technical data for Marstacimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 0UB3OA67O7.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1985638-39-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

0UB3OA67O7

CAS Registry Number

1985638-39-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

MARSTACIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

0UB3OA67O7

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C166436

National Cancer Institute reference terminology for clinical and research data.

INN ID

10789

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

EF-60

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Marstacimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MARSTACIMAB

MARSTACIMAB-HNCQ

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN TISSUE FACTOR PATHWAY INHIBITOR) (HUMAN MONOCLONAL PF-06741086 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL PF-06741086 .LAMBDA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-LAMBDA, ANTI-(HUMAN TISSUE FACTOR PATHWAY INHIBITOR (TFPI, EXTRINSIC PATHWAY INHIBITOR, EPI, LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR, LACI))

MARSTACIMAB [INN]

MARSTACIMAB [USAN]

MARSTACIMAB [WHO-DD]

MARSTACIMAB HNCQ [WHO-DD]

Brand / Trade Names

HYMPAVZI

Systematic Nomenclature

IMMUNOGLOBULIN G1-LAMBDA, ANTI-(HUMAN TISSUE FACTOR PATHWAY INHIBITOR (TFPI, EXTRINSIC PATHWAY INHIBITOR, EPI, LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR, LACI)) HUMAN MONOCLONAL ANTIBODY .GAMMA.1 HEAVY CHAIN (1-449) (HUMAN VH (HOMO SAPIENS IGHV-23*01(IGHD)-IGHJ3*02) (8.8.13) (1-120)-HOMO SAPIENS IGHG1*03 (CH1 R97>K(217), CH2 L4>A(237),L5>A(238),G7>A(240), CH3 K107>-(DEL)) (121-449)) (223-217')-DISULFIDE WITH LAMBDA LIGHT CHAIN (1'-218') (HUMAN V-LAMBDA (HOMO SAPIENS IGLV1-40*01-IGLJ2*01) (9.3.12) (1'-112')-HOMO SAPIENS IGLC2*01 (113'-218')) DIMER (229-229'':232-232'')-BISDISULFIDE

SYS